Skip to main content
. 2014 Mar 19;6(2):e00140. doi: 10.1042/AN20140006

Figure 7. LTP induced with 20 μM Roscovitine is prevented in the presence of the NMDA receptor antagonist AP5 (50 μM) or L-type calcium blocker Nifedipine (10 μM).

Figure 7

(A) Representative traces of population spikes in the presence of 50 μM AP5. AP5 reduced Roscovitine-LTP induction. (B) Representative traces of population spikes in the presence of 20 μM Roscovitine+10 μM Nifedipine. Nifedipine blocked Roscovitine-LTP induction. (C) Temporal course of population spikes in the presence of Roscovitine, Roscovitine+AP5 and Roscovitine+Nifedipine. (D) Box plot shows that population spikes amplitude increase triggered by Roscovitine was reduced significantly in the presence of AP5 or Nifedipine. (EG) PPR in the presence of Rosco vitine+AP5, Roscovitine+Nifedipine is shown. (H) PPR analysis of the experimental conditions. *P<0.001.